Media

For media inquiries, please contact: media@canntrust.ca

RECENT PRESS RELEASES

CannTrust Returns to the Canadian Marketplace

Adult Use Products under the LiivTM and Synr.gTM Brands In Market for Purchase VAUGHAN, ON, Dec. 2, 2020 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company") today announced it is returning to the Canadian cannabis marketplace with two of its recreational...

CannTrust Postpones Annual General Meeting Date

TORONTO, Sept. 16, 2020 /CNW/ - CannTrust Holdings Inc. ("CannTrust," or "the Company") today announced that the Ontario Superior Court of Justice, Commercial List, granted an order in the Company's proceeding under the Companies' Creditors Arrangement...

CannTrust Applies to Extend Time for Annual General Meeting

TORONTO, Sept. 10, 2020 /CNW/ - CannTrust Holdings Inc. ("CannTrust," or "the Company") today announced that the Company is seeking an order in its proceeding under the Companies' Creditors Arrangement Act ("CCAA") extending the time for CannTrust to call the next...

CannTrust Licenses Reinstated for Vaughan Manufacturing Facility

VAUGHAN, ON, Aug. 6, 2020  /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company") announced today that it has received notice from Health Canada that the Company's licenses for its Vaughan Manufacturing Facility (the "Vaughan facility") have been reinstated,...

CANNTRUST

Since 2013 CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories.

SUBSCRIBE TO INVESTOR NEWSLETTER

Subscribe Now

FOLLOW US

© CannTrust 2019

Terms & Conditions | Accessibility

Pin It on Pinterest